We invite you to attend Bioperfectus 2nd Global Distributors Conference

Company news


COVID-19 seems to pose a long-term battle for all the countries around the world, it is a must for bothBioperfectusand itsdistributorsto equip themselves with new skills and capabilities to cope with the post-pandemic era.


To navigate a healthier life, Bioperfectus is upgrading ourproductsandservicetocope with the fast-changing infectious disease diagnostic market. 


After successfully organizing Bioperfectus 1st Global Distributors Conference virtually, we are glad to bring together our latest progress and product information to present you Bioperfectus 2nd Global DistributorsConference.


CLICK HERE to register now!


Navigating a healthier life, we are waiting for you to board!


Bioperfectus Supports Cholera Elimination

SHANGHAI, CHINA, December 5, 2022—Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as “Bioperfectus”) is pleased to launch Vibrio Cholerae Real Time PCR Kits for human diagnosis and early warning surveillance.


Client Story: A Race Against Time

Through a critical assessment of clinical evaluation and data validation, Bioperfetus successfully passed the Israeli ministry of health inspection. Bioperfetus was the only Chinese company on the procurement list and was asked to provide one million antigen rapid test kits for the Israeli ministry of health.


Bioperfectus Granted MDA Approval in Malaysia for Nucleic Acid Extraction Systems

SHANGHAI, CHINA, November 14, 2022—Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as “Bioperfectus”), a leading global company in the molecular diagnostics market, today announced receipt of MDA (Medical Device Authority) approval in Malaysia for Nucleic Acid Extraction Systems, including Nucleic Acid SSNP-2000B, SSNP-3000A, SSNP-9600A, SMPE-960 and Extraction Rapid Kit (Magnetic Bead Method).